Skip to main content

ADVERTISEMENT

Maria Asimopoulos

Quiz
11/21/2022
Maria Asimopoulos
If a patient received 4 mg of apixaban less than 8 hours ago, which andexanet alfa dosing regimen should be administered to reverse anticoagulation?
If a patient received 4 mg of apixaban less than 8 hours ago, which andexanet alfa dosing regimen should be administered to reverse anticoagulation?
If a patient received 4 mg of...
11/21/2022
Veterans Health Today
Quiz
11/18/2022
Maria Asimopoulos
What is the recommended dosage of famotidine for patients with gastroesophageal reflux disease (GERD) who weigh at least 40 kg?
What is the recommended dosage of famotidine for patients with gastroesophageal reflux disease (GERD) who weigh at least 40 kg?
What is the recommended dosage...
11/18/2022
Pharmacy Learning Network
Online Exclusive
11/14/2022
Maria Asimopoulos
Our readership reported staffing and scheduling issues as the leading cause of burnout among pharmacists. What actions, if any, has your organization taken to address burnout?
Our readership reported staffing and scheduling issues as the leading cause of burnout among pharmacists. What actions, if any, has your organization taken to address burnout?
Our readership reported staffing...
11/14/2022
Pharmacy Learning Network
News
11/14/2022
Maria Asimopoulos
Investigators compared the efficacy and safety of vonoprazan and esomeprazole in patients with gastroesophageal reflux disease who responded only partially to proton pump inhibitors.
Investigators compared the efficacy and safety of vonoprazan and esomeprazole in patients with gastroesophageal reflux disease who responded only partially to proton pump inhibitors.
Investigators compared the...
11/14/2022
Pharmacy Learning Network
Poll
11/11/2022
Maria Asimopoulos
In your experience, which of the following is the biggest contributor to pharmacist burnout?
In your experience, which of the following is the biggest contributor to pharmacist burnout?
In your experience, which of the...
11/11/2022
Pharmacy Learning Network
Conference Coverage
11/09/2022
Maria Asimopoulos
Speakers at the 22nd Population Health Colloquium shared how laboratory services might be utilized better to reduce costs and improve care quality across large populations.
Speakers at the 22nd Population Health Colloquium shared how laboratory services might be utilized better to reduce costs and improve care quality across large populations.
Speakers at the 22nd Population...
11/09/2022
Population Health
Headshot of Nikolaos Sideris, Aristotle University, Thessaloniki, Greece
Interview
11/01/2022
Maria Asimopoulos
Nikolaos Sideris, MD, PhD candidate-scientific associate, First Department of Dermatology, Aristotle University Medical School, Thessaloniki, Greece, reviews the current state of practice and research in atopic dermatitis, emphasizing the...
Nikolaos Sideris, MD, PhD candidate-scientific associate, First Department of Dermatology, Aristotle University Medical School, Thessaloniki, Greece, reviews the current state of practice and research in atopic dermatitis, emphasizing the...
Nikolaos Sideris, MD, PhD...
11/01/2022
First Report Managed Care
News
10/31/2022
Maria Asimopoulos
"After controlling for other risk factors, reported gum disease among adults with [intellectual disabilities] may be associated with a higher risk of CVD," researchers found.
"After controlling for other risk factors, reported gum disease among adults with [intellectual disabilities] may be associated with a higher risk of CVD," researchers found.
"After controlling for other...
10/31/2022
Dentistry
News
10/31/2022
Maria Asimopoulos
Changes in site-of-service lowered the real-world costs of an anti-CD20 monoclonal antibody for commercial payers over time, according to recent findings.
Changes in site-of-service lowered the real-world costs of an anti-CD20 monoclonal antibody for commercial payers over time, according to recent findings.
Changes in site-of-service...
10/31/2022
First Report Managed Care
News
10/28/2022
Maria Asimopoulos
Researchers analyzed phase 3 data to understand dupilumab's efficacy in adults with moderate to severe atopic dermatitis depending on age of disease onset.
Researchers analyzed phase 3 data to understand dupilumab's efficacy in adults with moderate to severe atopic dermatitis depending on age of disease onset.
Researchers analyzed phase 3...
10/28/2022
First Report Managed Care